Hendriks D - Search Results

1

Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different in vitro models.

Leenaerts D, Loyau S, Mertens JC, Boisseau W, Michel JB, Lambeir AM, Jandrot-Perrus M, Hendriks D. Leenaerts D, et al. Among authors: hendriks d. J Thromb Haemost. 2018 Oct;16(10):2057-2069. doi: 10.1111/jth.14249. Epub 2018 Aug 30. J Thromb Haemost. 2018. PMID: 30053349 Free article.

2

Dipeptide-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl peptidase IV.

Lambeir AM, Borloo M, De Meester I, Belyaev A, Augustyns K, Hendriks D, Scharpé S, Haemers A. Lambeir AM, et al. Among authors: hendriks d. Biochim Biophys Acta. 1996 May 21;1290(1):76-82. doi: 10.1016/0304-4165(96)00012-8. Biochim Biophys Acta. 1996. PMID: 8645710

3

Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition of fibrinolysis.

Schatteman KA, Goossens FJ, Scharpé SS, Hendriks DF. Schatteman KA, et al. Among authors: hendriks df. Thromb Haemost. 1999 Dec;82(6):1718-21. Thromb Haemost. 1999. PMID: 10613660

4

Carboxypeptidase U at the interface between coagulation and fibrinolysis.

Schatteman K, Goossens F, Leurs J, Verkerk R, Scharpé S, Michiels JJ, Hendriks D. Schatteman K, et al. Among authors: hendriks d. Clin Appl Thromb Hemost. 2001 Apr;7(2):93-101. doi: 10.1177/107602960100700203. Clin Appl Thromb Hemost. 2001. PMID: 11292199 Free article. Review.

5

Local proCPU (TAFI) activation during thrombolytic treatment in a dog model of coronary artery thrombosis can be inhibited with a direct, small molecule thrombin inhibitor (melagatran).

Mattsson C, Björkman JA, Abrahamsson T, Nerme V, Schatteman K, Leurs J, Scharpé S, Hendriks D. Mattsson C, et al. Among authors: hendriks d. Thromb Haemost. 2002 Apr;87(4):557-62. Thromb Haemost. 2002. PMID: 12008935

6

Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma.

Leurs J, Wissing BM, Nerme V, Schatteman K, Björquist P, Hendriks D. Leurs J, et al. Among authors: hendriks d. Thromb Haemost. 2003 Feb;89(2):264-71. Thromb Haemost. 2003. PMID: 12574805

7

Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism.

Leurs J, Nerme V, Sim Y, Hendriks D. Leurs J, et al. Among authors: hendriks d. J Thromb Haemost. 2004 Mar;2(3):416-23. doi: 10.1111/j.1538-7836.2004.00605.x. J Thromb Haemost. 2004. PMID: 15009457 Free article.

8

Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease.

Leurs J, Hendriks D. Leurs J, et al. Among authors: hendriks d. Thromb Haemost. 2005 Sep;94(3):471-87. doi: 10.1160/TH04-07-0454. Thromb Haemost. 2005. PMID: 16268459 Review.

9

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI).

Bertina RM, van Tilburg NH, Haverkate F, Bouma BN, von dem Borne PA, Meijers JC, Campbell W, Eaton D, Hendriks DF, Willemse JL. Bertina RM, et al. Among authors: hendriks df. J Thromb Haemost. 2006 Jan;4(1):256-7. doi: 10.1111/j.1538-7836.2005.01666.x. J Thromb Haemost. 2006. PMID: 16409476 Free article. No abstract available.

10

A role for procarboxypepidase U (TAFI) in thrombosis.

Willemse JL, Hendriks DF. Willemse JL, et al. Front Biosci. 2007 Jan 1;12:1973-87. doi: 10.2741/2203. Front Biosci. 2007. PMID: 17127436 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters